Erratum to Squarticles as a Lipid Nanocarrier for Delivering Diphencyprone and Minoxidil to Hair Follicles and Human Dermal Papilla Cells (AAPS J, 10.1208/s12248-013-9550-y);Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells

AAPS Journal

Volumn 16, Issue 1, 2014, Pages 140-150

  Aljuffali, Ibrahim A ^a   Sung, Calvin T ^b   Shen, Feng Ming ^c   Huang, Chi Ting ^c,d   Fang, Jia You ^c,d,e  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Alopecia; Diphencyprone; Drug targeting; Hair follicles; Minoxidil; Squarticles

Indexed keywords

DIPHENCYPRONE; MINOXIDIL; NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; SQUARTICLE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DERMAL PAPILLA CELL; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; FEMALE; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HAIR FOLLICLE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION; SKIN ABSORPTION; SKIN CELL; SKIN IRRITATION; SKIN PENETRATION; UPREGULATION; ZETA POTENTIAL;

ANIMALS; CELLS, CULTURED; CYCLOPROPANES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HAIR FOLLICLE; HUMANS; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MINOXIDIL; NANOPARTICLES; SEBUM; SKIN IRRITANCY TESTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASODILATOR AGENTS;

EID: 84893608860     PISSN: 15507416     EISSN: 15507416     Source Type: Journal    
DOI: 10.1208/s12248-014-9692-6     Document Type: Erratum

References (49)

1. MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG. Guidelines for the management of alopecia areata. Br J Dermatol. 2003;149:692-9.
2. Avgerinou G, Gregoriou S, Rigopoulos D, Stratigos A, Kalogeromitros D, Katsambas A. Alopecia areata: topical immunotherapy treatment with diphencyprone. J Eur Acad Dermatol Venereol. 2008;22:320-3.
3. Messenger AG, Rundegren J. Minoxidil: mechnisms of action on hair growth. Br J Dermatol. 2004;150:186-94.
4. Tsuboi R, Itami S, Inui S, Ueki R, Katsuoka K, Kurata S, et al. Guidelines for the management of androgenetic alopecia (2010). J Dermatol. 2011;38:1-8.
5. Pray WS. Prevention and treatment of hair loss in men. US Pharmasist. 2008;33:16-20.
6. Alkhalifah A, Alsantali A, Wang E, EcElwee KJ, Shapiro J. Alopecia areata update. Part II. Treatment. J Am Acad Dermatol. 2010;62:191-202.
7. Mura S, Manconi M, Sinico C, Valenti D, Fadda AM. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm. 2009;380:72-9.
8. Georgala S, Befon A, Maniatopoulou E, Georgala C. Topical use of minoxidil in children and systemic side effects. Dermatology. 2007;214:101-2.
9. Zhao Y, Brown MB, Jones SA. The effects of particle properties on nanoparticle drug retention and release in dynamic minoxidil foams. Int J Pharm. 2010;383:277-84.
10. Baspinar Y, Keck CM, Borchert HH. Development of a positively charged prednicarbate nanoemulsion. Int J Pharm. 2010;383:201-8.
11. Wen CJ, Yen TC, Al-Suwayeh SA, Chang HW, Fang JY. In vivo real-time fluorescence visualization and brain-targeting mechanisms of lipid nanocarriers with different fatty ester:oil ratios. Nanomedicine. 2011;6:1545-59.
12. Huang ZR, Lin YK, Fang JY. Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. Molecules. 2009;14:540-54.
13. Blume-Peytavi U, Vogt A. Human hair follicle: reservoir function and selective targeting. Br J Dermatol. 2011;165 Suppl 2:13-7.
14. Campbell CSJ, Contreras-Rojas LR, Delgado-Charro MB, Guy RH. Objective assessment of nanoparticle disposition in mammalian skin after topical exposure. J Control Release. 2012;162:201-7.
15. Teichmann A, Jacobi U, Ossadnik M, Richter H, Koch S, Sterry W, et al. Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. J Invest Dermatol. 2005;125:264-9.
16. Lachgar S, Charveron M, Gall Y, Bonafe JL. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol. 1998;138:407-11.
17. Zhang LW, Al-Suwayeh SA, Hsieh PW, Fang JY. A comparison of skin delivery of ferulic acid and its derivatives: evaluation of their efficacy and safety. Int J Pharm. 2010;399:44-51.
18. Gargs S, Messenger AG. Alopecia areata: evidence-based treatments. Semin Cutan Med Surg. 2009;28:15-8.
19. Padois K, Cantiéni C, Bertholle V, Bardel C, Pirot F, Falson F. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil. Int J Pharm. 2011;416:300-4.
20. Lin CH, Fang YP, Al-Suwayeh SA, Yang SY, Fang JY. Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment. Biol Pharm Bull. 2013;36:276-86.
21. Kovacevic A, Savic S, Vuleta G, Müller RH, Keck CM. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm. 2011;406:163-72.
22. Shim J, Seok SH, Park WS, Han SH, Kim J, Chang IS. Transdermal delivery of minoxidil with block copolymer nanoparticles. J Control Release. 2004;97:477-84.
23. Mura S, Manconi M, Valenti D, Sinico C, Vila AO, Fadda AM. Transcutol containing vesicles for topical delivery of minoxidil. J Drug Target. 2011;19:189-96.
24. Yamashita N, Tachibana K, Ogawa K, Tsujita N, Tomita A. Scanning electron microscopic evaluation of the skin surface after ultrasound exposure. Anat Rec. 1997;247:455-61.
25. Lee WR, Shen SC, Pai MH, Yang HH, Yuan CY, Fang JY. Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium: YAG laser. J Control Release. 2010;145:124-33.
26. O'goshi K, Iguchi M, Tagami H. Functional analysis of the stratum corneum of scalp skin: studies in patients with alopecia areata and androgenetic alopecia. Arch Dermatol Res. 2000;292:605-11.
27. Betz RC, Pforr J, Flaquer A, Redler S, Hanneken S, Eigelshoven S, et al. Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J Invest Dermatol. 2007;127:2539-43.
28. 14C cortisol in man. J Invest Dermatol. 1967;48:181-3.
29. Grice JE, Ciotti S, Weiner N, Lockwood P, Cross SE, Roberts MS. Relative uptake of minoxidil into appendages and stratum corneum and permeation through human skin in vitro. J Pharm Sci. 2010;99:712-8.
30. Kwon TK, Kim JC. In vitro skin permeation of monolein nanoparticles containing hydroxypropyl β-cyclodextrin/minoxidil complex. Int J Pharm. 2010;392:268-73.
31. Jain B, Singh B, Katare OP, Vyas SP. Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units. J Liposome Res. 2010;20:105-14.
32. Cirri M, Bragagni M, Mennini N, Mura P. Development of a new delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for ketoprofen topical delivery. Eur J Pharm Biopharm. 2012;80:46-53.
33. Lombardi Borgia S, Regehly M, Sivaramakrishnan R, Mehnert W, Korting HC, Danker K, et al. Lipid nanoparticles for skin penetration enhancement- correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release. 2005; 110:151-63.
34. Lin YK, Al-Suwayeh SA, Leu YL, Shen FM, Fang JY. Squalenecontaining nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata. Pharm Res. 2013;30:435-46.
35. Abdel-Mottaleb NMA, Neumann D, Lamprecht A. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. Eur J Pharm Biopharm. 2011;79:36-42.
36. Wang JJ, Liu KS, Sung KC, Tsai CY, Fang JY. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers, and solid lipid nanoparticles. J Microencapsul. 2009;26:734-47.
37. Lin YK, Huang ZR, Zhuo RZ, Fang JY. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomed. 2010;5:117-28.
38. Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol. 2004;122:14-9.
39. Rolland A, Wagner N, Chatelus A, Shroot B, Schaefer H. Sitespecific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm Res. 1993;10:1738-44.
40. Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol. 2004;123:168-76.
41. Lademann J, Weigmann HJ, Rickmeyer C, Barthelmes H, Schaefer H, Müller G, et al. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol. 1999;12:247-56.
42. Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, et al. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol. 2006;126:1316-22.
43. Tur E, Maibach HI, Guy RH. Percutaneous penetration of methyl nicotinate at three anatomic sites: evidence for an appendageal contribution to transport? Skin Pharmacol. 1991;4:230-4.
44. Wosicka H, Cal K. Targeting to the hair follicles: current status and potential. J Dermatol Sci. 2010;57:83-9.
45. Ogiso T, Shiraki T, Okajima K, Tanino T, Iwaki M, Wada T. Transfollicular drug delivery: penetration of drugs through human scalp skin and comparison of penetration between scalp and abdominal skins in vitro. J Drug Target. 2002;10:369-78.
46. Otberg N, Patzelt A, Rasulev U, Hagemeister T, Linscheid M, Sinkgraven R, et al. The role of hair follicles in the percutaneous absorption of caffeine. Br J Clin Pharmacol. 2007;65:488-92.
47. Driskell RR, Clavel C, Rendl M, Watt FM. Hair follicle dermal papilla cells at a glance. J Cell Sci. 2011;124:1179-82.
48. Han JH, Kwon OS, Chung JH, Cho KH, Eun HC, Kim KH. Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle. J Dermatol Sci. 2004;34:91-8.
49. Castro GA, Coelho ALLR, Oliveira CA, Machecha GAB, Oréfice RL, Ferreira LAM. Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. Int J Pharm. 2009;381:77-83.